← Back to Clinical Trials
Recruiting NCT06483893

NCT06483893 Ultrasound-Guided Thyroid Cartilage Plane Block vs Ultrasound-Guided Traditional Superior Laryngeal Nerve Block for Awake Fiberoptic Intubation in Patients With Limited Neck Mobility Undergoing Cervical Spine Fixation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06483893
Status Recruiting
Phase
Sponsor Beni-Suef University
Condition Patient Satisfaction
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-07-01
Primary Completion 2024-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
US-guided thyroid cartilage plane block (group TCPB)US-guided traditional superior laryngeal nerve block (group traditional SLNB)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-07-01 with a primary completion date of 2024-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the work to compare between the effectiveness and safety of ultrasound-guided superior laryngeal nerve block through surface injection of local anesthetic solution on the thyroid cartilage and ultrasound-guided traditional superior laryngeal nerve block on quality of airway anesthesia for awake fiberoptic intubation in patients with limited neck mobility undergoing cervical spine fixation.

Eligibility Criteria

Inclusion Criteria: * patients aged between 18-65 years * either gender * ASA I-II * limited neck mobility Exclusion Criteria: * patients who refuse to give consent * non-cooperative patients * have asthma or ischemic heart disease * preoperative hoarseness, sore throat * mental or neurological disorders * contraindications for regional block (coagulopathy , infection at the needle insertion site and allergy to local anesthetics) * body mass index (BMI) \>26 kg/m2.

Contact & Investigator

Central Contact

Dina M Fakhry, MD

✉ dina_fakhry_91@yahoo.com

📞 +201289998680

Principal Investigator

Dina M Fakhry

PRINCIPAL INVESTIGATOR

Beni-Suef University

Frequently Asked Questions

Who can join the NCT06483893 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Patient Satisfaction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06483893 currently recruiting?

Yes, NCT06483893 is actively recruiting participants. Contact the research team at dina_fakhry_91@yahoo.com for enrollment information.

Where is the NCT06483893 trial being conducted?

This trial is being conducted at Banī Suwayf, Egypt.

Who is sponsoring the NCT06483893 clinical trial?

NCT06483893 is sponsored by Beni-Suef University. The principal investigator is Dina M Fakhry at Beni-Suef University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology